• Vol. 39 No. 11, 868–869
  • 15 November 2010

Management of a Patient with Schizophrenia and Underlying Pituitary Macroadenoma

34



Hyperprolactinemia was found to be prevalent in a multi-centred study of 402 patients with schizophrenia, schizoaffective disorder and schizophreniform disorder treated with conventional antipsychotics and Risperidone. Antipsychotics inhibit the dopamine receptors and induce hyperprolactinemia via the tubulo-infundibular pathway, with subsequent downstream effects on multiple systems.

This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.